Is ABBV or AMRN more undervalued in 2026?

CirclFi compares AbbVie Inc. (ABBV) and Amarin Corporation plc (AMRN) using 13 institutional-grade valuation models. ABBV has a Quality of Company score of 7.7/10 while AMRN scores 6.1/10.

Which is a better buy — ABBV or AMRN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ABBV and AMRN valuations compare?

ABBV at $218.63 and AMRN at $14.41 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ABBV vs AMRN Valuation Comparison 2026 — Intrinsic Value Analysis

ABBV

Drug Manufacturers - General

AbbVie Inc.

Quality

7.7

out of 10

Value Trap

SAFE

Price

$218.63

Last close

Models

12/13

Active

AMRN

Drug Manufacturers - General

Amarin Corporation plc

Quality

6.1

out of 10

Value Trap

LOW

Price

$14.41

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	ABBV Fair Value	ABBV Upside	AMRN Fair Value	AMRN Upside
Bayesian DCF	Intrinsic	$204.40	-6.5%	$10.03	-30.4%
Earnings Power Value	Intrinsic	$8.92	-95.9%	$18.35	+30.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ABBV vs AMRN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ABBV vs AMRN — Which Stock Is More Undervalued?

ABBV scores higher with a 7.7/10 quality rating vs AMRN's 6.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing AbbVie Inc. (ABBV) and Amarin Corporation plc (AMRN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ABBV currently trades at $218.63 with a QOC of 7.7/10, while AMRN trades at $14.41 with a QOC of 6.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).